Document is current

Any future updates will be listed below

Post-Marketing Surveillance of Hepatitis A Virus Vaccine (Avaxim® 160U) in South Korea from 2011 to 2015

Crossref DOI link: https://doi.org/10.1007/s40121-019-0230-9

Published Online: 2019-01-23

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark